statistiche ricercatore

TOSI, GIOVANNA

Distribuzione geografica

Continente	#
NA - Nord America	8.672
EU - Europa	8.102
AS - Asia	1.909
SA - Sud America	16
Continente sconosciuto - Info sul continente non disponibili	8
AF - Africa	3
OC - Oceania	3
Totale	18.713

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	8.583
IT - Italia	4.313
UA - Ucraina	1.553
TR - Turchia	638
VN - Vietnam	582
SE - Svezia	560
DE - Germania	516
CN - Cina	447
FI - Finlandia	406
IE - Irlanda	297
SG - Singapore	177
GB - Regno Unito	157
RU - Federazione Russa	127
FR - Francia	106
CA - Canada	89
BE - Belgio	32
JP - Giappone	21
IN - India	20
BR - Brasile	13
EU - Europa	8
KR - Corea	8
NL - Olanda	8
IR - Iran	7
CZ - Repubblica Ceca	5
CH - Svizzera	4
LT - Lituania	3
PK - Pakistan	3
BY - Bielorussia	2
HK - Hong Kong	2
HR - Croazia	2
NZ - Nuova Zelanda	2
PL - Polonia	2
RS - Serbia	2
TW - Taiwan	2
AR - Argentina	1
AT - Austria	1
AU - Australia	1
DK - Danimarca	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
GR - Grecia	1
IL - Israele	1
ME - Montenegro	1
MK - Macedonia	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
VE - Venezuela	1
ZA - Sudafrica	1
Totale	18.713

Salva come PNG Salva come JPEG

Città	#
Milan	3.337
Jacksonville	1.191
Fairfield	928
Chandler	783
Woodbridge	609
Ashburn	551
Wilmington	428
Ann Arbor	424
Izmir	405
Princeton	398
Houston	392
Seattle	384
Dearborn	366
Nyköping	297
Dublin	295
Cambridge	287
Dong Ket	268
Boardman	235
Rome	230
Beijing	168
Singapore	165
San Mateo	138
Como	91
Toronto	80
San Diego	76
Ogden	69
New York	61
Düsseldorf	45
Dallas	40
Helsinki	35
Santa Clara	35
Hefei	34
Verona	33
Brussels	31
Nanjing	28
Chicago	26
Norwalk	25
Pune	20
Tokyo	20
Kunming	19
London	19
Los Angeles	19
Guangzhou	18
Falls Church	17
Jinan	16
Washington	16
Phoenix	13
Frankfurt am Main	11
Fuzhou	11
Munich	10
Kocaeli	9
Hangzhou	8
Kilburn	8
Nanchang	8
Hebei	7
Tehran	7
Xian	7
Auburn Hills	6
Changsha	6
Chongqing	6
Wuhan	6
Edinburgh	5
Perugia	5
Ponte Lambro	5
Shenyang	5
Zhengzhou	5
Berlin	4
Brno	4
Chengdu	4
Indiana	4
Lausanne	4
Aprilia	3
Baotou	3
Chiswick	3
Costa Mesa	3
Florence	3
Gangnam-gu	3
Hounslow	3
Huzhou	3
Islington	3
Monza	3
Ottawa	3
Prescot	3
Quzhou	3
Redmond	3
San Francisco	3
Seongbuk-gu	3
Shanghai	3
Taiyuan	3
Vergiate	3
Ürümqi	3
Acton	2
Amsterdam	2
Belgrade	2
Birmingham	2
Fiesole	2
Guiyang	2
Gumi	2
Hong Kong	2
Jinhua	2
Totale	13.398

Salva come PNG Salva come JPEG

Nome	#
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	187
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	179
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	174
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	174
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	168
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	167
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	159
The MHC class II transactivator: prey and hunter in infectious diseases	158
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	156
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	154
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	150
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	148
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	148
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	147
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	147
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	146
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	145
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	141
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	140
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	138
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	138
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	136
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	136
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	133
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	132
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis	131
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	131
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	130
HLA-DQ genotype in early onset insulin dependent diabetes mellitus	129
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	129
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR	125
MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?	125
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	125
Insight into the molecular mechanism of CIITA-mediated inhibition of HIV-1 and HTLV transactivators	125
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	125
Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters	124
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization	124
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA	124
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells	124
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication.	122
Role of the HLA-DQ genotype in IDDM susceptibility	121
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells	120
Autoimmunità e Malattie Autoimmuni	120
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	120
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes	120
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein	119
The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for Insulin-Dependent Diabetes Mellitus	119
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1	117
Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers	116
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas	115
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein	115
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines	115
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA	114
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses	113
HLA-DQB1 typing of north east italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-Enzyme Immunoassay (DEIA)	112
HTLV-2 Tax-2 transactivator increases the expression and the function of its inhibitor CIITA, the master regulator of HLA-II gene transcription	112
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	111
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	110
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication	109
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA	109
Block of Stat-1 activation in macrophages, undergoing bacterial phagocytosis causes CIITA reduced transcription and consequent impaired antigen presentation	108
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	108
Molecular typing of polymorphic genes by time-resolved fluorescence resonance energy transfer	108
Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines	108
Tat protein is an HIV-1 encoded SS-chemochine homolog that promotes migrationand upregulates CCR3 on human FceRI+ cells	106
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	106
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1B molecules after mycobacterial phagocytosis	105
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA	104
A dual defensive role of CIITA against retroviral infections	103
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	102
Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope associated HLA class II molecules reverse this effect	102
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	102
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	102
Apparente dissociazione tra fenotipo DR e genotipo MHC di classe II in IDDM	101
Associazione tra genotipo HLA-DQ e suscettibilità al Diabete insulino-Dipendente	100
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity	100
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential	98
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	96
Efficient antigen presentation and T cell activation by MHC class II molecules of CIITA-transfected epatocarcinoma cells	94
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	94
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	94
Control of mammary adenocarcinoma growth in vivo by gene therapy with the MHC class II transactivator CIITA	93
Evidence for a specific post- transcriptional mechanism controlling the expression of HLA-DQ, but not DR and DP molecules	93
CIITA, the Master Regulator of MHC Class II Gene Transcription, Targets the Viral Transactivator Tax-1 to Inhibit HTLV-I Viral Replication and NFKB Activation	93
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1	90
Regulation of HLA antigen expression in HIV infected cells	90
Espressione delle molecole HLA di classe II in cellule di epatocarcinoma classe II negative dopo trasfezione del transattivatore CIITA. Acquisizione della capacità di processare e presentare l'antigene	88
Analysis of microchimerism in thyroid autoimmune diseases	88
Regolazione dell'espressione dei geni del Complesso Maggiore di Istocompatibilità HLA e di CD4 in cellule infettate da HIV: effetto di TAT	87
HTLV-II è mitogenico per i precursori emopoietici CD34+. La presenza di molecole HLA di classe II sull'envelope virale annulla tale effetto	87
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis	87
Distinct subcellular localization of HTLV-1 HBZ oncoprotein in the ATL leukemic and HAM/TSP patients.	87
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan	86
Reduced expression of the AIR-1 gene product CIITA as the cause of HLA class II down-modulation in normal human macrophages during bacterial phagocytosis	86
HTLV-II Tax-2 increases the cell surface expression of HLA-II molecules by acting at the level of CIITA, the master regulator of HLA-II transcription	86
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity.	85
The HLA class II transcriptional activator (CIITA) blocks the function of HIV-1 Tat and inhibits viral replication	85
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication	85
Associazione tra HLA-DQB1 e diabete giovanile analizzata a livello molecolare per Southern e DEIA	85
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA)	85
Totale	11.808

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	69.289
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	69.289

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	1.999	0	0	0	0	0	340	476	400	211	292	44	236
2020/2021	2.667	28	282	81	265	62	272	83	287	431	102	242	532
2021/2022	1.700	211	223	152	133	42	48	57	123	83	222	159	247
2022/2023	2.159	252	86	120	258	159	493	0	292	312	63	69	55
2023/2024	4.884	816	801	919	824	877	310	50	40	155	20	9	63
2024/2025	801	10	45	483	50	107	106	0	0	0	0	0	0
Totale													18.779